| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000009818 |
| Receipt No. | R000011505 |
| Official scientific title of the study | Development of rapid detection methods on cancer-related antigen in blood serum samples from gastric and colon cancer patients |
| Date of disclosure of the study information | 2013/01/20 |
| Last modified on | 2016/04/15 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Development of rapid detection methods on cancer-related antigen in blood serum samples from gastric and colon cancer patients | |
| Title of the study (Brief title) | Rapid detection methods on gastric and colon cancer-related antigen in blood serum samples | |
| Region |
|
|
| Condition | |||||||
| Condition | Gastric cancer and colon cancer | ||||||
| Classification by specialty |
|
||||||
| Classification by malignancy | Malignancy | ||||||
| Genomic information | NO | ||||||
| Objectives | |
| Narrative objectives1 | Development of rapid detection methods on cancer-related antigen in blood serum from patients with digestive tract cancer. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection of cancer-related antigen. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) patients with histologically proven gastric and colon cancer. And benign disease patients without cancer.
(2) clinical solitary tumor (3) no prior treatment (4) age 20-80 years (5) Eastern Cooperative Oncology Group performance status 0 or 1 (6) sufficient organ function (7) written informed consent |
|||
| Key exclusion criteria | (1) synchronous or metachronous malignancy
(2) pregnant or breastfeeding women |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Ito, MD, PhD |
| Organization | Showa University Koto-Toyosu Hospital |
| Division name | Digestive Disease Center |
| Address | 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577 Japan |
| TEL | 03-6204-6000 |
| h.ito@med.showa-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroaki Ito, MD, PhD |
| Organization | Showa University Koto-Toyosu Hospital |
| Division name | Digestive Disease Center |
| Address | 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577 Japan |
| TEL | 03-6204-6000 |
| Homepage URL | |
| h.ito@med.showa-u.ac.jp | |
| Sponsor | |
| Institute | Digestive Disease Center, Showa University Koto-Toyosu Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Digestive Disease Center, Showa University Koto-Toyosu Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | The possibility was showed that this technique could diagnose gastric and colonic cancer by using serum samples from the patients. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011505 |